Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.
暂无分享,去创建一个
Glenn J Jaffe | Giovanni Staurenghi | Christian Simader | Paul Mitchell | Sebastian M Waldstein | Ursula Schmidt-Erfurth | P. Mitchell | U. Schmidt-Erfurth | S. Waldstein | C. Simader | G. Jaffe | G. Staurenghi | N. V. Chong | N Victor Chong | Chengxing Lu | Todd A Katz | Chengxing Lu | Sebastian M. Waldstein | Todd A. Katz
[1] Gerald Liew,et al. Ranibizumab for neovascular age-related macular degeneration. , 2007, The New England journal of medicine.
[2] Georg Langs,et al. Spatio-Temporal Signatures to Predict Retinal Disease Recurrence , 2015, IPMI.
[3] K Bailey Freund,et al. Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration? , 2010, Retina.
[4] William J Feuer,et al. QUANTITATIVE CHANGES IN RETINAL PIGMENT EPITHELIAL DETACHMENTS AS A PREDICTOR FOR RETREATMENT WITH ANTI-VEGF THERAPY , 2013, Retina.
[5] Bianca S. Gerendas,et al. Correlation of 3-Dimensionally Quantified Intraretinal and Subretinal Fluid With Visual Acuity in Neovascular Age-Related Macular Degeneration. , 2016, JAMA ophthalmology.
[6] Susan Schneider,et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[7] Christian Simader,et al. Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy , 2014, British Journal of Ophthalmology.
[8] Christian Simader,et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. , 2012, Ophthalmology.
[9] Georg Langs,et al. Predicting Semantic Descriptions from Medical Images with Convolutional Neural Networks , 2015, IPMI.
[10] Christian Simader,et al. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. , 2015, Ophthalmology.
[11] Francesco Bandello,et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) , 2014, British Journal of Ophthalmology.
[12] Glenn J Jaffe,et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. , 2014, Ophthalmology.
[13] Christian Simader,et al. Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres , 2008, British Journal of Ophthalmology.
[14] Glenn J Jaffe,et al. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. , 2013, Ophthalmology.
[15] U. Schmidt-Erfurth,et al. A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration , 2016, Progress in Retinal and Eye Research.